Cargando…
A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma
Molecular profiling of lung cancer has become essential for prediction of an individual’s response to targeted therapies. Next-generation sequencing (NGS) is a promising technique for routine diagnostics, but has not been sufficiently evaluated in terms of feasibility, reliability, cost and capacity...
Autores principales: | Shao, Di, Lin, Yongping, Liu, Jilong, Wan, Liang, Liu, Zu, Cheng, Shaomin, Fei, Lingna, Deng, Rongqing, Wang, Jian, Chen, Xi, Liu, Liping, Gu, Xia, Liang, Wenhua, He, Ping, Wang, Jun, Ye, Mingzhi, He, Jianxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776238/ https://www.ncbi.nlm.nih.gov/pubmed/26936516 http://dx.doi.org/10.1038/srep22338 |
Ejemplares similares
-
Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients
por: Liu, Liping, et al.
Publicado: (2017) -
GABR(A3) promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases
por: Liu, Liping, et al.
Publicado: (2016) -
Beyond finding druggable targets and tumor mutational burden: to measure heterogeneity by ctDNA
por: Liu, Zhichao, et al.
Publicado: (2020) -
Artificial intelligence in thoracic diseases: the next technology to improve individual precision medicine
por: Liang, Hengrui, et al.
Publicado: (2021) -
Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas
por: Wu, Kui, et al.
Publicado: (2015)